Ajinomoto Strikes Nursing Care Deal with Nestlè Japan

From April this year, the Japanese maker of aspartame will transfer its diets for protein-energy malnutrition business to Nestlè in Japan, which will handle all production and sales.
 
Additionally, Nestlè Japan will also conduct sales and promotion activities for Ajinomoto’s nutritional care foods while Ajinomoto will continue to carry out product development, production and research for the nutritional care foods.

 

Ajinomoto has made the deal as Nestlè Japan is strong in medical-channel sales and has a reputable medical and nursing care foods business.

 

On the other hand, Ajinomoto has strengths in product development, which leverages its amino acid research and food produce development technologies.

 

By coming together, the two companies believe it will help drive up sales.

 

The promotion of medication for the elderly presents a growing opportunity for companies in Japan and globally.

 

Nutrition therapy is gaining new attention as a way of enhancing the effects of treatment at medical intuitions, and there is a growing awareness of the importance of nutrition management for the elderly at home.

 

In 1969, Ajinomoto began launching products for nutrition management support.

 

Over the past 15 years, it has leveraged years of amino acid research combined with food product development technologies to launch products such as Aquasolita and Aminocare.